{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-015726","form_type":"8-K","ticker":"FBIO","cik":"0001429260","company_name":"Fortress Biotech, Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.431049+00:00","generated_at":"2026-05-30T00:24:00.242310+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Fortress Biotech Q3 net loss $15M; FDA approved Emrosi on Nov 4; cosibelimab PDUFA Dec 28","bullets":["Net loss attributable to common stockholders $15.0M ($0.76/shr) vs $7.1M loss in Q3 2023.","Consolidated net revenue $14.6M (all from dermatology products); Q3 2023 revenue $34.8M included $19M license fee.","Cash and equivalents $58.9M as of Sep 30, 2024, down $22M YTD; included $25.6M at Fortress and private subs.","Paused Series A preferred dividends in July 2024, deferring ~$0.7M cash/month; new $35M Oaktree loan terms.","FDA approval of Emrosi on Nov 4; cosibelimab PDUFA date Dec 28; Checkpoint raised $9.2M in Nov warrant exercises."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-015726","json":"https://secwatch.observer/filing/0001558370-24-015726.json","markdown":"https://secwatch.observer/filing/0001558370-24-015726.md","text":"https://secwatch.observer/filing/0001558370-24-015726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1429260/000155837024015726/0001558370-24-015726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1429260/000155837024015726/fbio-20241114x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:24:00.242310+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}